Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors

Stefano La Rosa, Catherine Klersy, Silvia Uccella, Linda Dainese, Luca Albarello, Angelica Sonzogni, Claudio Doglioni, Carlo Capella, Enrico Solcia

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

Currently used histopathologic criteria for the diagnosis of pancreatic endocrine tumors are still under discussion as far as to their capacity to identify prognostically different tumor subsets, which are potentially helpful for patient management. A recently developed TNM staging system and a variety of proposed histologic and clinicopathologic parameters still need to be fully validated. One hundred fifty-five pancreatic endocrine tumors encompassing all the main histologic types and stages, operated with intention to cure and then followed up for a median 126 months, were carefully investigated histologically to identify prognostically informative parameters at univariable, bivariable, and multivariable analysis. Ki67 index, mitotic rate, neuroinvasion with or without vascular, peritumoral or stromal infiltrative patterns, as well as tumor size, and association with endocrine syndromes other than insulinoma proved effective in predicting recurrence and disease-specific death among well-differentiated tumors. Poorly differentiated histologic features, more than 10 mitoses/10 high power fields, and necrosis were helpful in the identification of high-grade cancers with an invariably poor prognosis. The TNM system proved to be highly predictive of patient outcome and easy to combine with histologic and clinicopathologic parameters to classify pancreatic endocrine tumors into groups of increasing malignant potential.

Original languageEnglish
Pages (from-to)30-40
Number of pages11
JournalHuman Pathology
Volume40
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Neoplasms
Insulinoma
Mitotic Index
Neoplasm Staging
Mitosis
Blood Vessels
Necrosis
Recurrence

Keywords

  • Endocrine tumor
  • Pancreas
  • Predictor of malignancy
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. / La Rosa, Stefano; Klersy, Catherine; Uccella, Silvia; Dainese, Linda; Albarello, Luca; Sonzogni, Angelica; Doglioni, Claudio; Capella, Carlo; Solcia, Enrico.

In: Human Pathology, Vol. 40, No. 1, 01.2009, p. 30-40.

Research output: Contribution to journalArticle

@article{7a6a0a669739477d8df7d2ce1890204e,
title = "Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors",
abstract = "Currently used histopathologic criteria for the diagnosis of pancreatic endocrine tumors are still under discussion as far as to their capacity to identify prognostically different tumor subsets, which are potentially helpful for patient management. A recently developed TNM staging system and a variety of proposed histologic and clinicopathologic parameters still need to be fully validated. One hundred fifty-five pancreatic endocrine tumors encompassing all the main histologic types and stages, operated with intention to cure and then followed up for a median 126 months, were carefully investigated histologically to identify prognostically informative parameters at univariable, bivariable, and multivariable analysis. Ki67 index, mitotic rate, neuroinvasion with or without vascular, peritumoral or stromal infiltrative patterns, as well as tumor size, and association with endocrine syndromes other than insulinoma proved effective in predicting recurrence and disease-specific death among well-differentiated tumors. Poorly differentiated histologic features, more than 10 mitoses/10 high power fields, and necrosis were helpful in the identification of high-grade cancers with an invariably poor prognosis. The TNM system proved to be highly predictive of patient outcome and easy to combine with histologic and clinicopathologic parameters to classify pancreatic endocrine tumors into groups of increasing malignant potential.",
keywords = "Endocrine tumor, Pancreas, Predictor of malignancy, Prognosis",
author = "{La Rosa}, Stefano and Catherine Klersy and Silvia Uccella and Linda Dainese and Luca Albarello and Angelica Sonzogni and Claudio Doglioni and Carlo Capella and Enrico Solcia",
year = "2009",
month = "1",
doi = "10.1016/j.humpath.2008.06.005",
language = "English",
volume = "40",
pages = "30--40",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors

AU - La Rosa, Stefano

AU - Klersy, Catherine

AU - Uccella, Silvia

AU - Dainese, Linda

AU - Albarello, Luca

AU - Sonzogni, Angelica

AU - Doglioni, Claudio

AU - Capella, Carlo

AU - Solcia, Enrico

PY - 2009/1

Y1 - 2009/1

N2 - Currently used histopathologic criteria for the diagnosis of pancreatic endocrine tumors are still under discussion as far as to their capacity to identify prognostically different tumor subsets, which are potentially helpful for patient management. A recently developed TNM staging system and a variety of proposed histologic and clinicopathologic parameters still need to be fully validated. One hundred fifty-five pancreatic endocrine tumors encompassing all the main histologic types and stages, operated with intention to cure and then followed up for a median 126 months, were carefully investigated histologically to identify prognostically informative parameters at univariable, bivariable, and multivariable analysis. Ki67 index, mitotic rate, neuroinvasion with or without vascular, peritumoral or stromal infiltrative patterns, as well as tumor size, and association with endocrine syndromes other than insulinoma proved effective in predicting recurrence and disease-specific death among well-differentiated tumors. Poorly differentiated histologic features, more than 10 mitoses/10 high power fields, and necrosis were helpful in the identification of high-grade cancers with an invariably poor prognosis. The TNM system proved to be highly predictive of patient outcome and easy to combine with histologic and clinicopathologic parameters to classify pancreatic endocrine tumors into groups of increasing malignant potential.

AB - Currently used histopathologic criteria for the diagnosis of pancreatic endocrine tumors are still under discussion as far as to their capacity to identify prognostically different tumor subsets, which are potentially helpful for patient management. A recently developed TNM staging system and a variety of proposed histologic and clinicopathologic parameters still need to be fully validated. One hundred fifty-five pancreatic endocrine tumors encompassing all the main histologic types and stages, operated with intention to cure and then followed up for a median 126 months, were carefully investigated histologically to identify prognostically informative parameters at univariable, bivariable, and multivariable analysis. Ki67 index, mitotic rate, neuroinvasion with or without vascular, peritumoral or stromal infiltrative patterns, as well as tumor size, and association with endocrine syndromes other than insulinoma proved effective in predicting recurrence and disease-specific death among well-differentiated tumors. Poorly differentiated histologic features, more than 10 mitoses/10 high power fields, and necrosis were helpful in the identification of high-grade cancers with an invariably poor prognosis. The TNM system proved to be highly predictive of patient outcome and easy to combine with histologic and clinicopathologic parameters to classify pancreatic endocrine tumors into groups of increasing malignant potential.

KW - Endocrine tumor

KW - Pancreas

KW - Predictor of malignancy

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=56249088940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56249088940&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2008.06.005

DO - 10.1016/j.humpath.2008.06.005

M3 - Article

C2 - 18715612

AN - SCOPUS:56249088940

VL - 40

SP - 30

EP - 40

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 1

ER -